Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sergio L Schmidt, Michele Santos da Silva, Juliana J Schmidt, Ana Lucia Novais Carvalho, Claudia Cristina Ferreira Vasconcelos, Renata Alves Paes, Yolanda EM Boechat, Rafael Neder & Regina P Alvarenga. (2018) Neuropsychiatric assessments in patients with multiple sclerosis in early phases and with low disability. Neuropsychiatric Disease and Treatment 14, pages 1665-1670.
Read now
Read now
Emanuele D’Amico, Aurora Zanghì & Francesco Patti. (2016) Personalized therapy in multiple sclerosis: state of art and future perspectives. Expert Review of Precision Medicine and Drug Development 1:4, pages 353-360.
Read now
Read now
Alessandra Lugaresi, Maria Rosa Rottoli & Francesco Patti. (2014) Fostering adherence to injectable disease-modifying therapies in multiple sclerosis. Expert Review of Neurotherapeutics 14:9, pages 1029-1042.
Read now
Read now
Articles from other publishers (19)
Jacek Karczewski, Aleksandra Zielińska, Rafał Staszewski, Piotr Eder, Agnieszka Dobrowolska & Eliana B. Souto. (2022) Obesity and the Brain. International Journal of Molecular Sciences 23:11, pages 6145.
Crossref
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry
777
830
.
Carlos A. Perez, Andrew Smith & Flavia NelsonCarlos A. Pérez. 2021. Multiple Sclerosis. Multiple Sclerosis
157
176
.
A. R. Kabaeva & A. N. Boyko. (2020) Informative value of neuropsychological tests for multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics 12:1S, pages 33-37.
Crossref
Crossref
Katrin Pape, Ryad Tamouza, Marion Leboyer & Frauke Zipp. (2019) Immunoneuropsychiatry — novel perspectives on brain disorders. Nature Reviews Neurology 15:6, pages 317-328.
Crossref
Crossref
P. L. Jelinek, S. SimpsonJrJr, C. R. Brown, G. A. Jelinek, C. H. Marck, A. M. De Livera, E. O'Kearney, K. L. Taylor, S. L. Neate & T. J. Weiland. (2018) Self‐reported cognitive function in a large international cohort of people with multiple sclerosis: associations with lifestyle and other factors. European Journal of Neurology 26:1, pages 142-154.
Crossref
Crossref
Charlene Cui, Jing Wang, Ariana P. Mullin, Anthony O. Caggiano, Tom J. Parry, Raymond W. Colburn & Elias Pavlopoulos. (2018) The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination. Brain Research 1694, pages 73-86.
Crossref
Crossref
William James Deardorff & George T. Grossberg. 2018. Clinical Psychopharmacology for Neurologists. Clinical Psychopharmacology for Neurologists
151
180
.
Giancarlo Comi, Francesco Patti, Maria Assunta Rocca, Flavia Caterina Mattioli, Maria Pia Amato, Paolo Gallo, Diego Centonze, Carlo Pozzilli, Francesco Saccà, Florian Then Bergh, Marta Bartezaghi, Renato Turrini & Massimo Filippi. (2017) Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study). Journal of Neurology 264:12, pages 2436-2449.
Crossref
Crossref
Bilge Piri Cinar, G?rkem K?sehasano?ullar?Pinar Yigit & Serkan Ozakbas. (2016) Cognitive dysfunction in patients with multiple sclerosis treated with first-line disease-modifying therapy: a multi-center, controlled study using the BICAMS battery. Neurological Sciences 38:2, pages 337-342.
Crossref
Crossref
M. Mückschel, C. Beste & T. Ziemssen. (2016) Immunomodulatory treatments and cognition in MS. Acta Neurologica Scandinavica 134, pages 55-59.
Crossref
Crossref
Nastaran Majdinasab, Amir Siahpush, Seyedeh Khatoon Mousavinejad, Alireza Malayeri, Seyed Aidin Sajedi & Parisa Bizhanzadeh. (2016) Effect of Boswellia serrata on cognitive impairment in multiple sclerosis patients. Journal of Herbal Medicine 6:3, pages 119-127.
Crossref
Crossref
Nikolaos Korakas & Magda Tsolaki. (2016) Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments. Cognitive and Behavioral Neurology 29:2, pages 55-67.
Crossref
Crossref
Abdorreza Naser Moghadasi, Shadi Pourmand, Maryam Sharifian, Alireza Minagar & Mohammad Ali Sahraian. (2016) Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies. Neurologic Clinics 34:1, pages 17-31.
Crossref
Crossref
Francois H Jacques, Brian T Harel, Adrian J Schembri, Chantal Paquette, Brigitte Bilodeau, Pawel Kalinowski & Reshmi Roy. (2016) Cognitive evolution in natalizumab-treated multiple sclerosis patients. Multiple Sclerosis Journal - Experimental, Translational and Clinical 2, pages 205521731665711.
Crossref
Crossref
P.S. Sorensen, K. Schreiber & A.K. Andreasen. 2016. Translational Neuroimmunology in Multiple Sclerosis. Translational Neuroimmunology in Multiple Sclerosis
347
364
.
Jun-Jun Sun, Qing-Guo Ren, Lin Xu & Zhi-Jun Zhang. (2015) LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice. Scientific Reports 5:1.
Crossref
Crossref
Jun-Jang Jin, Il-Gyu Ko, Sung-Eun Kim, Mal-Soon Shin, Sang-Hoon Kim & Yong-Seok Jee. (2014) Swimming exercise ameliorates multiple sclerosis-induced impairment of short-term memory by suppressing apoptosis in the hippocampus of rats. Journal of Exercise Rehabilitation 10:2, pages 69-74.
Crossref
Crossref
Francesco Patti, Vincenzo Brescia Morra, Maria Pia Amato, Maria Trojano, Stefano Bastianello, Maria Rosalia Tola, Salvatore Cottone, Andrea Plant & Orietta Picconi. (2013) Subcutaneous Interferon ?-1a May Protect against Cognitive Impairment in Patients with Relapsing?Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study. PLoS ONE 8:8, pages e74111.
Crossref
Crossref